3,722 papers found
Refreshing results…
Improvement of GPS-attached Pocket PM2.5 Measuring Device for Personal Exposure Assessment
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy
EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice
Prediction of disease-associated circRNAs via circRNA-disease pair graph and weighted nuclear norm minimization
QPG-dominated transient flow behavior of a well in a subsurface formation
CircRNA-disease associations prediction based on metapath2vec++ and matrix factorization
Generalized SCL-Flip Decoding of Polar Codes
Three-dimensional porous CoNiO2@reduced graphene oxide nanosheet arrays/nickel foam as a highly efficient bifunctional electrocatalyst for overall water splitting
Comprehensive Evaluation of Immune-Checkpoint DNA Cancer Vaccines in a Rat Cholangiocarcinoma Model
Comparison of 4 sinus augmentation techniques for implant placement with residual alveolar bone height ≤3 mm
Co-activation of Akt, Nrf2, and NF-κB signals under UPRER in torpid Myotis ricketti bats for survival
ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner
Chromosomal Instability May Not Be a Predictor for Immune Checkpoint Inhibitors from a Comprehensive Bioinformatics Analysis
Real-world cost-effectiveness associated with infliximab maintenance therapy for moderate to severe Crohn’s disease in China
The effectiveness of neurology resident EEG training for seizure recognition in critically ill patients
Research on the Fluid Flow Characteristics in the Process of Pump Closing in Cementing
A sustainable and efficient preparation process of anthocyanins from blue honeysuckle fruit and comprehensive bioactivity assessment
A Predictive-Trend-Aware and Critical-Path-Estimation-Based Method for Workflow Scheduling Upon Cloud Services
Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases
Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
Missing publications? Read more about our data sources.